 |
|
Melanoma Trial Results
6. Interferon Superior to a GMK Vaccine in Preventing Melanoma Relapse
(Posted: 05/04/2001, Reviewed: 05/25/2005) - High-dose interferon proved superior to a GMK ganglioside vaccine, a potentially promising cancer therapy, in protecting high-risk patients against a recurrence of their melanoma, according to research from a multicenter clinical trial published in the May 1, 2001, Journal of Clinical Oncology.
7. High-Dose Interferon Prolongs Time to Recurrence in Melanoma
(Posted: 02/20/2001, Reviewed: 03/23/2005) - High-dose interferon alfa-2b significantly prolongs the time before melanoma recurs compared to low-dose interferon or no therapy, according to the findings of a large, randomized clinical trial.
8. Chemoimmunotherapy No Better Than Combination Chemotherapy Alone for Metastatic Melanoma
(Posted: 11/10/1999, Reviewed: 03/23/2005) - A prospective randomized clinical trial at the National Cancer Institute finds that aggressive treatment for metastatic melanoma that combines chemotherapy drugs with immunotherapy agents yields survival results no better than that of treatment with combination chemotherapy alone.
< Previous 1 2
|
|
|
